NOVAVAX Elects Richard H. Douglas to its Board of... ( ROCKVILLE Md. Stanley Erck stated...)

NOVAVAX Elects Richard H. Douglas to its Board of Directors

Date:8/6/2010

ROCKVILLE, Md., Aug. 6 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today the appointment of Richard Douglas, Ph.D. to its board of directors. Dr. Douglas is currently Senior Vice President, Corporate Development at Genzyme Corp. As a leader of Genzyme's Corporate Development team, Dr. Douglas has been involved in numerous acquisitions, licenses, joint ventures and strategic alliances as well as Genzyme's venture investments. He has served in a variety of corporate and product development positions with Genzyme since he joined Integrated Genetics (now Genzyme) as a staff scientist in 1982.

Novavax Chairman Stanley Erck stated: "Richard has more than twenty-five years of corporate, business and product development experience at Genzyme which will be extremely valuable to Novavax as we advance our vaccine candidates. His expertise in business development, technology assessment and protein chemistry will be especially helpful in guiding our future discovery, development and commercialization programs. We welcome his counsel and contributions to our future success."

Dr. Douglas currently serves on the national advisory board of the University of Michigan Technology Transfer Office and previously served as a director of Iomai Corporation and Synthon Chiragenics. He received his doctorate in biochemistry from the University of California at Berkeley and his bachelor's degree in chemistry from the University of Michigan.

About Novavax

Novavax, Inc.
'/>"/>

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3
Related biology technology :

1. Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer
2. Novavax Announces Manufacturing Management Appointments
3. Novavax Announces Publication of a Pre-clinical Study with its Pandemic 2009 H1N1 Influenza Virus-Like Particle (VLP) Vaccine
4. NOVAVAX Completes Enrollment of Pivotal H1N1 Influenza Vaccine Clinical Trial in Mexico
5. NOVAVAX to Present at the 12th Annual BIO CEO & Investor Conference
6. NOVAVAX to Present at Phacilitate Vaccine Forum Washington 2010
7. NOVAVAX Announces Positive Preclinical Results for its Respiratory Syncytial Virus (RSV) Vaccine Candidate
8. NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference
9. NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults
10. Novavax Prices Public Offering of Common Stock
11. NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico

Post Your Comments:

(Date:5/23/2013)... MARINO, Calif. , May 23, 2013 /PRNewswire/ ... today a strategic alliance with DAK Renewable Research ... the corn oil yield. VG Energy is a ... (OTC Pink: VGLS). VG Energy,s exclusively ... to increase the oil yield in plants, possessing ...

(Date:5/23/2013)... , May 23, 2013 Virobay, Inc. today ... pain has reached an important milestone, as Virobay has ... - a selective cathepsin S inhibitor. ... double-blind, randomized, placebo-controlled study designed to evaluate the safety, ... in healthy adults. "The initiation of this ...

(Date:5/23/2013)... (PRWEB) May 23, 2013 On April ... trips to supermarkets to search for the growing antibiotic ... aisles. Results from a year long study were released ... in foods, specifically meats, over previous years. For those ... the growth of antibiotic resistant bacteria in food, may ...

(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy. (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...

Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2 VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3 Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2 Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3 Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2 NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2 NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3

[0] VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials [0] Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain [0] Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria [0] NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer

... Shire plc (LSE: SHP, NASDAQ: SHPGY ), the ... to September 30, 2011. Financial Highlights Q3 ... +24% Non GAAP operating income $341 million +15% US GAAP ... ADS $1.28 +10% US GAAP diluted earnings per ADS $1.02 ...

... of Colorado Boulder study shows that huge amounts of ... promote healthy heart growth, results that may have implications ... Leinwand and her research team found the amount of ... oils -- in the blood of Burmese pythons one ...

... at the Georgia Institute of Technology have developed a ... a key ingredient found in many explosives. ... on paper or paper-like material using standard inkjet technology, ... to the presence of explosives, such as improvised explosive ...

Shire plc: Continued Strong Product Sales Performance in Q3: On Track to Deliver Significant 2011 Earnings Growth CU-Boulder python study may have implications for human heart health Low-cost paper-based wireless sensor could help detect explosive devices

(Date:5/24/2013)... non-coding RNAs are small molecules that help control ... they have emerged as disease biomarkers. miRNA profiles ... cancers of unknown primary origin, determine prognosis, monitor ... tractable, diagnostic methods for monitoring miRNA expression in ... issue of the Journal of Clinical Investigation ...

(Date:5/24/2013)... 500 leading water scientists from around the world today ... the short span of one or two generations, the ... be living under the handicap of severe pressure on ... there is no substitute. This handicap will be self-inflicted ... bluntly pointed to chronic underlying problems led by mismanagement ...

(Date:5/23/2013)... Laboratory honored more than 165 staff for their ... PNNL,s annual Intellectual Property Commercialization Recognition & Rewards ... national laboratory named materials scientist Jun Liu Inventor ... materials that can store large amounts of energy, ... the time it takes to charge cell phones, ...

Breaking Biology News(10 mins):A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2 A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3 A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4 PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2

[0] New fluorescent tools for cancer diagnosis [0] A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists [1] PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace

... COLUMBIA, Mo. An incurable, paralyzing disease in humans is ... Researchers from the University of Missouri and the Broad ... degenerative myelopathy (DM) in dogs is the same mutation ... also known as Lou Gehrig,s Disease. As a result ...

... insecticide used to fumigate termite-infested buildings is a strong ... times longer than previously thought, UC Irvine research has ... the atmosphere at least 30-40 years and perhaps as ... lifetime at as low as five years, grossly underestimating ...

... the University of Leicester has published research which looks into ... being exposed to. Research published today (Jan 20) ... Archives of Disease in Childhood documents the non-drug ... as part of their medical care. The study led ...

Cached Biology News:Researchers genetically link Lou Gehrig's disease in humans to dog disease 2 Termite insecticide a potent greenhouse gas 2 Research exposes the risk to infants from the chemicals used in liquid medicines 2 Research exposes the risk to infants from the chemicals used in liquid medicines 3

Researchers genetically link Lou Gehrig's disease in humans to dog disease Termite insecticide a potent greenhouse gas Research exposes the risk to infants from the chemicals used in liquid medicines

... new Hummingbird has the ability to quickly and ... makes it a perfect candidate for inclusion in ... OCX interface supplied with all the Cartesian products ... Hummingbirds ability to copy plates in seconds ...

Sigmas E-TOXATE (Limulus Amebocyte Lysate) test kits are intended for the detection and semiquantitation of endotoxins for research purposes. sensitivity 0.05-0.1 EU/mL...

... isolation chamber provides a safe, clean ... pharmaceuticals, in accord with USP-797 requirements. ... (ISO 5) cleanliness conditions in the ... rod and tilt-up front panel for ...

... Protein determined by Biuret. Physical ... (NH 4 ) 2 SO ... Note: Affinity purified • Physical ... Additives: MgCl 2 1 ...

Biology Products:

Hummingbird for Compound Library Management from Genomic Solutions Endotoxin Gel formation Assay Kit, E-TOXATE from Sigma-Aldrich Pharmaceutical Compounding Chamber from Terra Universal, Inc.Bovine Phosphatase, Alkaline bovine intestinal mucosa, Unconjugated from Sigma-Aldrich